WallStreetZenWallStreetZen

NASDAQ: GOSS
Gossamer Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GOSS

Based on 5 analysts offering 12 month price targets for Gossamer Bio Inc

Min Forecast
$0.30-32.74%
Avg Forecast
$2.06+361.88%
Max Forecast
$5.00+1,021.08%

Should I buy or sell GOSS stock?

Based on 5 analysts offering ratings for Gossamer Bio Inc.

Hold
Strong Buy
0 analysts 0%
Buy
2 analysts 40%
Hold
2 analysts 40%
Sell
0 analysts 0%
Strong Sell
1 analysts 20%

Be the first to know when Wall Street analysts revise their GOSS stock forecasts and price targets.

GOSS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-06
lockedlocked$00.00+00.00%2026-03-05
lockedlocked$00.00+00.00%2026-02-24
lockedlocked$00.00+00.00%2026-02-24
lockedlocked$00.00+00.00%2026-02-24

1 of 1

Forecast return on equity

Is GOSS forecast to generate an efficient return?

Company
-45.5%
Industry
67.35%
Market
157.69%
GOSS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GOSS forecast to generate an efficient return on assets?

Company
32.43%
Industry
31.29%
GOSS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GOSS earnings per share forecast

What is GOSS's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$0.49
Avg 2 year Forecast
-$0.19
Avg 3 year Forecast
$0.00

GOSS revenue forecast

What is GOSS's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$20.5M-57.63%
Avg 2 year Forecast
$61.9M+27.79%
Avg 3 year Forecast
$135.7M+180%
GOSS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GOSS revenue growth forecast

How is GOSS forecast to perform vs Biotechnology companies and vs the US market?

Company
38.71%
Industry
38.34%
Market
14.4%
GOSS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GOSS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GOSS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GOSS$0.45$2.06+361.88%Hold
PYXS$1.66$7.00+321.69%Strong Buy
PMN$11.53$26.50+129.84%Strong Buy
TTRX$3.46$8.00+131.21%Strong Buy
CGTX$1.19$3.33+180.08%Strong Buy
View Top Biotech Stocks

Gossamer Bio Stock Forecast FAQ

Is Gossamer Bio Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: GOSS) stock is to Hold GOSS stock.

Out of 5 analysts, 0 (0%) are recommending GOSS as a Strong Buy, 2 (40%) are recommending GOSS as a Buy, 2 (40%) are recommending GOSS as a Hold, 0 (0%) are recommending GOSS as a Sell, and 1 (20%) are recommending GOSS as a Strong Sell.

If you're new to stock investing, here's how to buy Gossamer Bio stock.

What is GOSS's earnings growth forecast for 2026-2028?

(NASDAQ: GOSS) Gossamer Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.74%.

Gossamer Bio's earnings in 2026 is -$170,370,000.On average, 11 Wall Street analysts forecast GOSS's earnings for 2026 to be -$114,907,299, with the lowest GOSS earnings forecast at -$181,701,861, and the highest GOSS earnings forecast at -$49,286,219. On average, 11 Wall Street analysts forecast GOSS's earnings for 2027 to be -$45,108,625, with the lowest GOSS earnings forecast at -$98,901,013, and the highest GOSS earnings forecast at -$3,942,898.

In 2028, GOSS is forecast to generate $680,619 in earnings, with the lowest earnings forecast at -$151,801,555 and the highest earnings forecast at $194,680,565.

What is GOSS's revenue growth forecast for 2026-2028?

(NASDAQ: GOSS) Gossamer Bio's forecast annual revenue growth rate of 38.71% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.34%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.4%.

Gossamer Bio's revenue in 2026 is $48,471,000.On average, 11 Wall Street analysts forecast GOSS's revenue for 2026 to be $4,819,488,130, with the lowest GOSS revenue forecast at $0, and the highest GOSS revenue forecast at $9,304,768,757. On average, 11 Wall Street analysts forecast GOSS's revenue for 2027 to be $14,537,322,341, with the lowest GOSS revenue forecast at $4,554,046,637, and the highest GOSS revenue forecast at $27,658,956,716.

In 2028, GOSS is forecast to generate $31,852,979,257 in revenue, with the lowest revenue forecast at $5,015,459,525 and the highest revenue forecast at $87,292,934,755.

What is GOSS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: GOSS) forecast ROA is 32.43%, which is higher than the forecast US Biotechnology industry average of 31.29%.

What is GOSS's Price Target?

According to 5 Wall Street analysts that have issued a 1 year GOSS price target, the average GOSS price target is $2.06, with the highest GOSS stock price forecast at $5.00 and the lowest GOSS stock price forecast at $0.30.

On average, Wall Street analysts predict that Gossamer Bio's share price could reach $2.06 by Mar 6, 2027. The average Gossamer Bio stock price prediction forecasts a potential upside of 361.88% from the current GOSS share price of $0.45.

What is GOSS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: GOSS) Gossamer Bio's current Earnings Per Share (EPS) is -$0.75. On average, analysts forecast that GOSS's EPS will be -$0.49 for 2026, with the lowest EPS forecast at -$0.77, and the highest EPS forecast at -$0.21. On average, analysts forecast that GOSS's EPS will be -$0.19 for 2027, with the lowest EPS forecast at -$0.42, and the highest EPS forecast at -$0.02. In 2028, GOSS's EPS is forecast to hit $0.00 (min: -$0.65, max: $0.83).

What is GOSS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: GOSS) forecast ROE is -45.5%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.